A LOW-PREVALENCE OF CORONARY HEART-DISEASE AMONG SUBJECTS WITH INCREASED HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS, INCLUDING THOSE WITH PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY
Y. Moriyama et al., A LOW-PREVALENCE OF CORONARY HEART-DISEASE AMONG SUBJECTS WITH INCREASED HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS, INCLUDING THOSE WITH PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN-DEFICIENCY, Preventive medicine, 27(5), 1998, pp. 659-667
Citations number
46
Categorie Soggetti
Public, Environmental & Occupation Heath","Medicine, General & Internal
Background. Use of genetic analysis may improve the predictive value o
f risk factors for disease. A high plasma level of high-density lipopr
otein (HDL) cholesterol is a strong negative risk factor for coronary
heart disease (CHD). Cholesteryl ester transfer protein (CETP) deficie
ncy causes increased levels of HDL cholesterol, However, recent studie
s suggest that CETP deficiency is a risk factor for CHD despite elevat
ed HDL cholesterol levels, Methods. Plasma lipid levels, CHD prevalenc
e, resting electrocardiograms, and common CETP gene mutations were ana
lyzed cross-sectionally in a population of 19,044 male and 29,487 fema
le Japanese subjects (ages 45-79 years). Results. High HDL cholesterol
levels (serum HDL cholesterol greater than or equal to 80 mg/dl, grea
ter than or equal to 95th percentile) were found in 6 and 5% of Japane
se men and women, respectively. In the group with HDL cholesterol grea
ter than or equal to 80 mg/dl, common CETP gene mutations were identif
ied in 23-24% of men and 31-49% of women. The prevalence of CHD in the
group with high HDL cholesterol (greater than or equal to 80 mg/dl) w
as low among both men (1.0%) and women (1.3%). There was no difference
in CHD prevalence between hyper-HDL-cholesterolemic subjects with and
without CETP mutations. Conclusions. Subjects with very high HDL leve
ls (HDL cholesterol greater than or equal to 80 mg/dl) as well as mild
-to-moderate HDL elevations (60-79 mg/dl) appear to be protected again
st CHD, whether or not they have CETP deficiency, a genetic cause of e
levated HDL. (C) 1998 American Health Foundation and Academic Press.